The timing is stark. Two major bacterial outbreaks in two years. And two years since the last dedicated AMR budget measure expired.
Read More
The Queensland Drug Discovery Alliance (QDDA) Symposium held recently in Brisbane, was a testament to the robust ecosystem being built around world‑class discovery and development expertise. And for enabling new technologies such as New Approach Methodologies (NAMs).
Read More
Specially developed for US sponsors and partners on practical approaches to global trial delivery, and just prior to BIO!
Read More
In this webinar, find out more about the TTRA Devices Round 2 investment opportunity, providing up to $1 million to help eligible Australian start-ups, spin-outs and SMEs develop innovative preventative, diagnostic, therapeutic and/or disease management devices for cardiovascular disease and the complications of diabetes (type 1 and type 2).
Read More
